{{Rsnum
|rsid=3923087
|Gene=AXIN2
|Chromosome=17
|position=65553143
|Orientation=minus
|GMAF=0.4789
|Gene_s=AXIN2
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 13.3 | 28.3 | 58.4
| HCB | 41.2 | 44.9 | 14.0
| JPT | 50.4 | 38.9 | 10.6
| YRI | 86.3 | 13.7 | 0.0
| ASW | 53.6 | 39.3 | 7.1
| CHB | 41.2 | 44.9 | 14.0
| CHD | 49.5 | 36.7 | 13.8
| GIH | 12.9 | 45.5 | 41.6
| LWK | 80.9 | 16.4 | 2.7
| MEX | 5.3 | 66.7 | 28.1
| MKK | 48.7 | 39.1 | 12.2
| TSI | 13.7 | 37.3 | 49.0
| HapMapRevision=28
}}{{PMID Auto
|PMID=24078348
|Title=An Analysis of Polymorphisms Within the Wnt Signaling Pathway in Relation to Ovarian Cancer Risk in a Polish Population
|OA=1
}}

{{PMID Auto
|PMID=18708403
|Title=Association of genetic variation in genes implicated in the beta-catenin destruction complex with risk of breast cancer.
|OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}